8-KItem 1.01 · Material AgreementItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
C.H. Robinson to acquire RXO in $5.8 billion stock-and-cash deal
Filed with the SEC on · Summarized by InvestorsBot
C.H. Robinson and RXO announced on October 5, 2026, that C.H. Robinson will acquire RXO for an implied $5.8 billion, with RXO shareholders receiving $17.25 in cash and 0.0856 C.H. Robinson shares per RXO share, or implied consideration of $30.25 per share. The deal is expected to close in the first half of 2027, subject to regulatory and RXO shareholder approvals, and C.H. Robinson projects about $300 million in annual run-rate cost synergies within two years, adjusted EPS accretion within nine months, and mid-teens adjusted EPS accretion in 2028.